Professor Xiao Baichun is NonExecutive Independent Director of Biostime International Holdings Ltd. Professor Xiao is a professional and scholar in management science. Professor Xiao has academic background and experience in business management, which is relevant to the business operations in matters relating to corporate governance practices. From April 1994, he was with Seton Hall University as an associate professor and was promoted to professor in March 1999. He was also the chairman of computing and decision sciences department of Seton Hall University in 1998. Since September 1998, he was with Long Island University pursuing his teaching career and is now a senior professor. He has also been the chairman of the department of management of Long Island University since 18 September 2005. Professor Xiao was appointed by various universities in China as either a chair professor or a visiting professor. For example, he was a faculty member of Peking University since January 2005, a visiting professor of Chinese University of Hong Kong, a guest professor and a director of Chinese American Center for service and operation management in Southwest Jiaotong University since May 2004, a distinguished professor of EMBA program in Fudan University since August 2005 and a lifetime professor of the management school of Sichuan University since May 2000. As a testament to his achievement, Professor Xiao received various awards in his research area. Professor Xiao was named as Fulbright Senior Scholar by US Fulbright Foundation in 2012. Professor Xiao currently serves as a member of the board of directors of Nanjing University. Professor Xiao received a bachelor?s degree in mathematics from Nanjing University in July 1982, a MBA degree from Catholic University of Leuven, Belgium in March 1985, and his Ph.D. from Wharton School, University of Pennsylvania in December 1990.
Non-Executive Independent Director
Age: 64 Director Since 2010 MBA
The company has return on total asset (ROA) of 20.99 % which means that it generated profit of $20.99 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 34.56 % meaning that it generated $34.56 on every $100 dollars invested by stockholders.
The company has accumulated 43.14 M in total debt with debt to equity ratio (D/E) of 0.12 which may suggest the company is not taking enough advantage from borrowing. Biostime International Holdings Limited China has Current Ratio of 1.98 which is within standard range for the sector.
Entity SummaryBiostime International Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pediatric nutritional and baby care products. Biostime International Holdings Limited China  is traded on Hong Kong Stock Exchange in Hong Kong. It is located in Guangzhou, and employs 24 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| 1112 Hong Kong #KYG112591014HK
Biostime International Holdings Limited China
Biostime International Holdings Limited China has less than 1.0 (%) percent chance of experiencing financial distress in the next 2 years of operations.
Biostime price boundaries
Promote Biostime and Baichun Xiao